{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:36:42Z","timestamp":1781876202693,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13555-021-00631-8","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T16:03:20Z","timestamp":1635264200000},"page":"2159-2177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7603-3007","authenticated-orcid":false,"given":"Mahreen","family":"Ameen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-4346","authenticated-orcid":false,"given":"Stephan","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1502","authenticated-orcid":false,"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-1145","authenticated-orcid":false,"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8726-6658","authenticated-orcid":false,"given":"Angele","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"(the BADEL Study Group)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"8 Suppl","key":"631_CR1","first-page":"S115","volume":"23","author":"C Avena-Woods","year":"2017","unstructured":"Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115\u201323 (PMID: 28978208).","journal-title":"Am J Manag Care"},{"issue":"10023","key":"631_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(15)00149-X.","journal-title":"Lancet"},{"issue":"6","key":"631_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, et\u00a0al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393. https:\/\/doi.org\/10.1111\/all.13401.","journal-title":"Allergy"},{"issue":"2","key":"631_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","volume":"40","author":"J Kim","year":"2019","unstructured":"Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40(2):84\u201392. https:\/\/doi.org\/10.2500\/aap.2019.40.4202.","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"631_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","volume":"137","author":"AM Drucker","year":"2017","unstructured":"Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137(1):26\u201330. https:\/\/doi.org\/10.1016\/j.jid.2016.07.012.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"631_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/pde.13727","volume":"36","author":"EJ Yang","year":"2019","unstructured":"Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol. 2019; 36(1):66\u201371. https:\/\/doi.org\/10.1111\/pde.13727.","journal-title":"Pediatr Dermatol"},{"key":"631_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2147\/JAA.S317009","volume":"14","author":"L Stingeni","year":"2021","unstructured":"Stingeni L, Belloni Fortina A, Baiardini I, et\u00a0al. Atopic dermatitis and patient perspectives: insights of bullying at school and career discrimination at work. J Asthma Allergy. 2021;14:919\u201328. https:\/\/doi.org\/10.2147\/JAA.S317009.","journal-title":"J Asthma Allergy"},{"key":"631_CR8","doi-asserted-by":"publisher","unstructured":"Wollenberg A, Barbarot S, Bieber T, et\u00a0al.; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients\u2019 Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657\u2013682. https:\/\/doi.org\/10.1111\/jdv.14891.","DOI":"10.1111\/jdv.14891"},{"key":"631_CR9","doi-asserted-by":"publisher","unstructured":"Wollenberg A, Barbarot S, Bieber T, et\u00a0al.; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients\u2019 Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part\u00a0II. J Eur Acad Dermatol Venereol. 2018;32(6):850\u2013878. https:\/\/doi.org\/10.1111\/jdv.14888.","DOI":"10.1111\/jdv.14888"},{"key":"631_CR10","unstructured":"Kearns DG, Uppal SK, Chat VS, Wu JJ. Phase 2 and 3 trials of JAK inhibitors for atopic dermatitis: a review. Practical Dermatol. 2020:50\u201354."},{"issue":"3","key":"631_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bph.14550","volume":"177","author":"K Schaper-Gerhardt","year":"2020","unstructured":"Schaper-Gerhardt K, Rossbach K, Nikolouli E, Werfel T, Gutzmer R, Mommert S. The role of the histamine H4 receptor in atopic dermatitis and psoriasis. Br J Pharmacol. 2020;177(3):490\u2013502. https:\/\/doi.org\/10.1111\/bph.14550.","journal-title":"Br J Pharmacol"},{"issue":"9","key":"631_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1080\/21645515.2019.1582403","volume":"15","author":"Q Thibodeaux","year":"2019","unstructured":"Thibodeaux Q, Smith MP, Ly K, Beck K, Liao W, Bhutani T. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019;15(9):2129\u201339. https:\/\/doi.org\/10.1080\/21645515.2019.1582403.","journal-title":"Hum Vaccin Immunother"},{"key":"631_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14862","author":"K Hansel","year":"2021","unstructured":"Hansel K, Patruno C, Antonelli E, et\u00a0al. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2021. https:\/\/doi.org\/10.1111\/ced.14862.","journal-title":"Clin Exp Dermatol"},{"key":"631_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15035","volume":"2021","author":"L Stingeni","year":"2021","unstructured":"Stingeni L, Hansel K, Antonelli E, et\u00a0al. Atopic dermatitis in adolescents: effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dematol Ther. 2021:e15035. https:\/\/doi.org\/10.1111\/dth.15035.","journal-title":"Dematol Ther"},{"issue":"4","key":"631_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jdv.17094","volume":"35","author":"C Patruno","year":"2021","unstructured":"Patruno C, Napolitano M, Argenziano G, DADE\u2014Dupilumab for Atopic Dermatitis of the Elderly study group, et\u00a0al. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol. 2021;35(4):958\u201364. https:\/\/doi.org\/10.1111\/jdv.17094.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"631_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40257-021-00597-5","volume":"22","author":"C Patruno","year":"2021","unstructured":"Patruno C, Fabbrocini G, Longo G, Dupilumab for Atopic Dermatitis of the Elderly (DADE) Study Group, et\u00a0al. Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis: a multicenter real-life observational study. Am J Clin Dermatol. 2021;22(4):581\u20136. https:\/\/doi.org\/10.1007\/s40257-021-00597-5.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"631_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.anai.2020.08.016","volume":"126","author":"N Puar","year":"2021","unstructured":"Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):21\u201331. https:\/\/doi.org\/10.1016\/j.anai.2020.08.016.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"631_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00497-w","author":"M Berruyer","year":"2021","unstructured":"Berruyer M, Delaunay J. Atopic dermatitis: a patient and dermatologist\u2019s perspective. Dermatol Ther (Heidelb). 2021. https:\/\/doi.org\/10.1007\/s13555-021-00497-w.","journal-title":"Dermatol Ther (Heidelb)."},{"key":"631_CR19","doi-asserted-by":"publisher","unstructured":"Marron SE, Cebrian-Rodriguez J, Alcalde-Herrero VM, Garcia-Latasa de Aranibar FJ, Tomas-Aragones L. Psychosocial Impact of Atopic Dermatitis in Adults: A Qualitative Study. Actas Dermosifiliogr. 2020;111(6):513\u2013517. https:\/\/doi.org\/10.1016\/j.ad.2019.03.018.","DOI":"10.1016\/j.ad.2019.03.018"},{"issue":"7","key":"631_CR20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/jdv.15634","volume":"33","author":"J Ring","year":"2019","unstructured":"Ring J, Zink A, Arents BWM, et\u00a0al. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults. J Eur Acad Dermatol Venereol. 2019;33(7):1331\u201340. https:\/\/doi.org\/10.1111\/jdv.15634.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"597","key":"631_CR21","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.3399\/bjgp12X636083","volume":"62","author":"M Santer","year":"2012","unstructured":"Santer M, Burgess H, Yardley L, et\u00a0al. Experiences of carers managing childhood eczema and their views on its treatment: a qualitative study. Br J Gen Pract. 2012;62(597):e261\u20137. https:\/\/doi.org\/10.3399\/bjgp12X636083.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"631_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3122\/jabfm.2020.04.190449","volume":"33","author":"P Fleming","year":"2020","unstructured":"Fleming P, Yang YB, Lynde C, O\u2019Neill B, Lee KO. Diagnosis and management of atopic dermatitis for primary care providers. J Am Board Fam Med. 2020;33(4):626\u201335. https:\/\/doi.org\/10.3122\/jabfm.2020.04.190449.","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"631_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13555-017-0192-3","volume":"7","author":"C Jeon","year":"2017","unstructured":"Jeon C, Yan D, Nakamura M, et\u00a0al. Frequency and management of sleep disturbance in adults with atopic dermatitis: a systematic review. Dermatol Ther (Heidelb). 2017;7(3):349\u201364. https:\/\/doi.org\/10.1007\/s13555-017-0192-3.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"631_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00489-w","author":"AC Fougerousse","year":"2021","unstructured":"Fougerousse AC. At the dawn of a therapeutic revolution for atopic dermatitis: an interview with Dr Anne-Claire Fougerousse. Dermatol Ther (Heidelb). 2021. https:\/\/doi.org\/10.1007\/s13555-021-00489-w.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"631_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","volume":"137","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Silverberg JI, Guttman-Yassky E, Councilors of the International Eczema Council, et\u00a0al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137(1):18\u201325. https:\/\/doi.org\/10.1016\/j.jid.2016.08.022.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"631_CR26","doi-asserted-by":"publisher","first-page":"e017731","DOI":"10.1136\/bmjopen-2017-017731","volume":"7","author":"LM Howells","year":"2017","unstructured":"Howells LM, Chalmers JR, Cowdell F, Ratib S, Santer M, Thomas KS. \u201cWhen it goes back to my normal I suppose\u201d: a qualitative study using online focus groups to explore perceptions of \u201ccontrol\u201d among people with eczema and parents of children with eczema in the UK. BMJ Open. 2017;7(11):e017731. https:\/\/doi.org\/10.1136\/bmjopen-2017-017731.","journal-title":"BMJ Open"},{"key":"631_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19631","author":"AV Sears","year":"2020","unstructured":"Sears AV, Woolf RT, Gribaleva E, et\u00a0al. Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.19631.","journal-title":"Br J Dermatol"},{"issue":"2","key":"631_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/ijd.14573","volume":"59","author":"C Wang","year":"2020","unstructured":"Wang C, Kraus CN, Patel KG, Ganesan AK, Grando SA. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients\u2019 records. Int J Dermatol. 2020;59(2):253\u20136. https:\/\/doi.org\/10.1111\/ijd.14573.","journal-title":"Int J Dermatol"},{"issue":"10","key":"631_CR29","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1111\/ijd.15053","volume":"59","author":"NS Kim","year":"2020","unstructured":"Kim NS, Maliyar K, Oliveira L, O\u2019Toole A, Gooderham MJ. Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis. Int J Dermatol. 2020;59(10):e361\u20133. https:\/\/doi.org\/10.1111\/ijd.15053.","journal-title":"Int J Dermatol"},{"issue":"10","key":"631_CR30","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1111\/jdv.16329","volume":"34","author":"C Pascal","year":"2020","unstructured":"Pascal C, Maucort-Boulch D, Gilibert S, et\u00a0al. Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria. J Eur Acad Dermatol Venereol. 2020;34(10):2339\u201345. https:\/\/doi.org\/10.1111\/jdv.16329.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"631_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/ibd\/izz122","volume":"26","author":"KM De Felice","year":"2020","unstructured":"De Felice KM. Patients perception of risks and benefits of biologic therapy. Inflamm Bowel Dis. 2020;26(1):147\u20139. https:\/\/doi.org\/10.1093\/ibd\/izz122.","journal-title":"Inflamm Bowel Dis"},{"key":"631_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/CCID.S300402","volume":"14","author":"AC Fougerousse","year":"2021","unstructured":"Fougerousse AC, Jacobzone C, Mery-Bossard L, GEM ResoEczema Group, et\u00a0al. Use of systemic medications for treating adult atopic dermatitis in france: results of a practice survey. Clin Cosmet Investig Dermatol. 2021;14:179\u201383. https:\/\/doi.org\/10.2147\/CCID.S300402.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"631_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.anai.2020.07.026","volume":"126","author":"JI Silverberg","year":"2021","unstructured":"Silverberg JI, Guttman-Yassky E, Gadkari A, Kuznik A, et\u00a0al. Real-world persistence with dupilumab among adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):40\u20135. https:\/\/doi.org\/10.1016\/j.anai.2020.07.026.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"631_CR34","first-page":"83","volume":"12","author":"SR Feldman","year":"2019","unstructured":"Feldman SR, Cox LS, Strowd LC, et\u00a0al. The challenge of managing atopic dermatitis in the United States. Am Health Drug Benefits. 2019;12(2):83\u201393.","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"631_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13063-016-1356-7","volume":"17","author":"T Keeley","year":"2016","unstructured":"Keeley T, Williamson P, Callery P, et\u00a0al. The use of qualitative methods to inform Delphi surveys in core outcome set development. Trials. 2016;17(1):230. https:\/\/doi.org\/10.1186\/s13063-016-1356-7.","journal-title":"Trials"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00631-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00631-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00631-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T04:08:31Z","timestamp":1637726911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00631-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00631-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}